The killing effect of rmhTNF-alpha combined with gemcitabine on human lung adenocarcinoma cells A549
Background and objective At present clinical researches has proven that the chemotherapeutic effect on advanced non-small cell lung cancer (NSCLC) has gotten to plateau. Biotherapy combined with chemotherapy could improve curative effect on advanced NSCLC obviously. The project is aiming at explorin...
Main Authors: | Cuiping GU, Yiping ZHANG, Jianguo FENG, Shenglin MA, Yanjun LU, Dan HONG, Jinlin CHEN |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2008-08-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.04.004&path%5B%5D=113 |
Similar Items
-
Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer
by: Tian Fu, et al.
Published: (2020-06-01) -
Effect of gemcitabine chemotherapy on immune function and VEGF in patients with middle and advanced liver cancer
by: Ling Zuo, et al.
Published: (2016-09-01) -
A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
by: Ma Yue, et al.
Published: (2011-03-01) -
Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy: A Case Report and Review of the Literature
by: M. Wiesweg, et al.
Published: (2014-02-01) -
Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01)